Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

September 2014

Pharmacy Researchers Battle Antibiotic-Resistant Superbugs

By

September 18th 2014

For Better Adherence Following Stroke, Provide Prescriptions at Discharge

By

September 18th 2014

FDA Fast-Tracks Pfizer's C Difficile Vaccine

By

September 18th 2014

Lean Six Sigma in the Pharmacy Department

ByJami Mann, PharmD, MBA,Allison Dipper, PharmD candidate,Erinn Rowe, PharmD, MS,Chad Hatfield, PharmD, MHA, BCPS

September 17th 2014

Respiratory Syncytial Virus Infection: Treatment and Prophylaxis

ByDaniel T. Lui, PharmD

September 17th 2014

Febrile Neutropenia in an Oncology Patient

ByMeredith Deal Keisler, PharmD, CPP

September 17th 2014

Sivextro by Cubist Pharmaceuticals

ByMichael R. Page, PharmD, RPh

September 17th 2014

The Future Health-System Pharmacy Department

ByStephen F. Eckel, PharmD, MHA, BCPS, FASHP, FAPhA, FCCP

September 17th 2014

SGLT2 Inhibitors: A New Treatment Option for Type 2 Diabetes

ByJennifer L. Simon, PharmD, CPP,Sarah Timaeus,Caron Misita, PharmD, BCPS, CDE, CPP

September 17th 2014

Trending on Pharmacy Times

Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy

Fall 2025 Quiz: Test Your Pharmacy Knowledge!

Hormone Therapy Use, Understanding, and Perceptions Have Positively Shifted From 2021 to 2025

New Data Show Elinzanetant Is a Safe, Well-Tolerated Non-Hormonal Therapy for Menopausal Vasomotor Symptoms

FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms

© 2025 MJH Life Sciences^®

All rights reserved.